Moberg Pharma AB (publ) (STO:MOB)
Sweden
· Delayed Price · Currency is SEK 10.18
-0.19 (-1.83%)
At close: Mar 9, 2026
Moberg Pharma AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 230.95 | 293.29 | 60.56 | 125.55 | 102.66 | Upgrade
|
| Cash & Short-Term Investments | 230.95 | 293.29 | 60.56 | 125.55 | 102.66 | Upgrade
|
| Cash Growth | -21.25% | 384.33% | -51.77% | 22.30% | 432.28% | Upgrade
|
| Accounts Receivable | 3.38 | 0.17 | - | 0.38 | 0.47 | Upgrade
|
| Other Receivables | - | 0.64 | 0.79 | 1.06 | 0.66 | Upgrade
|
| Receivables | 3.38 | 0.8 | 0.79 | 1.44 | 1.14 | Upgrade
|
| Inventory | 3.58 | 4.3 | 7.12 | - | - | Upgrade
|
| Prepaid Expenses | - | 1.58 | 0.9 | 0.72 | 0.75 | Upgrade
|
| Other Current Assets | - | 0.14 | 0.14 | 0.06 | 0.12 | Upgrade
|
| Total Current Assets | 237.91 | 300.11 | 69.49 | 127.76 | 104.66 | Upgrade
|
| Property, Plant & Equipment | 2.81 | 4.42 | 4.94 | 5.98 | 4.52 | Upgrade
|
| Long-Term Deferred Tax Assets | 92.58 | 95.78 | 28.08 | 22.58 | 14.67 | Upgrade
|
| Long-Term Deferred Charges | 348.96 | 305.77 | 532.22 | 408.1 | 327.04 | Upgrade
|
| Total Assets | 682.26 | 706.09 | 634.73 | 564.42 | 450.89 | Upgrade
|
| Accounts Payable | - | 4.16 | 6.77 | 17.11 | 5.31 | Upgrade
|
| Accrued Expenses | - | 10.67 | 12.5 | 7.56 | 7.45 | Upgrade
|
| Current Portion of Leases | 1.68 | 1.6 | 1.27 | 2.12 | 2.7 | Upgrade
|
| Other Current Liabilities | 14.5 | 0.29 | - | - | 0.09 | Upgrade
|
| Total Current Liabilities | 16.17 | 16.72 | 20.54 | 26.79 | 15.54 | Upgrade
|
| Long-Term Leases | 0.87 | 2.55 | 3.47 | 3.99 | 1.24 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | 0.07 | 0.07 | Upgrade
|
| Total Liabilities | 17.04 | 19.27 | 24.01 | 30.84 | 16.84 | Upgrade
|
| Common Stock | 47 | 46.69 | 27.96 | 9.83 | 4.41 | Upgrade
|
| Additional Paid-In Capital | 1,239 | 1,234 | 921.3 | 841.2 | 731.38 | Upgrade
|
| Retained Earnings | -620.88 | -593.64 | -338.53 | -317.44 | -301.73 | Upgrade
|
| Total Common Equity | 665.22 | 686.82 | 610.73 | 533.58 | 434.05 | Upgrade
|
| Shareholders' Equity | 665.22 | 686.82 | 610.73 | 533.58 | 434.05 | Upgrade
|
| Total Liabilities & Equity | 682.26 | 706.09 | 634.73 | 564.42 | 450.89 | Upgrade
|
| Total Debt | 2.55 | 4.14 | 4.74 | 6.11 | 3.93 | Upgrade
|
| Net Cash (Debt) | 228.4 | 289.15 | 55.82 | 119.45 | 98.72 | Upgrade
|
| Net Cash Growth | -21.01% | 418.02% | -53.27% | 20.99% | 730.24% | Upgrade
|
| Net Cash Per Share | 4.88 | 7.64 | 3.52 | 15.74 | 22.94 | Upgrade
|
| Filing Date Shares Outstanding | 47 | 46.69 | 27.96 | 9.83 | 4.4 | Upgrade
|
| Total Common Shares Outstanding | 47 | 46.69 | 27.96 | 9.83 | 4.4 | Upgrade
|
| Working Capital | 221.74 | 283.39 | 48.95 | 100.97 | 89.12 | Upgrade
|
| Book Value Per Share | 14.15 | 14.71 | 21.84 | 54.30 | 98.54 | Upgrade
|
| Tangible Book Value | 665.22 | 686.82 | 610.73 | 533.58 | 434.05 | Upgrade
|
| Tangible Book Value Per Share | 14.15 | 14.71 | 21.84 | 54.30 | 98.54 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.